Log in to save to my catalogue

Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis again...

Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis again...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd67a1f19aa74d5c92e2729047f7397f

Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil

About this item

Full title

Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil

Publisher

England: BioMed Central Ltd

Journal title

AIDS research and therapy, 2022-02, Vol.19 (1), p.12-12, Article 12

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Pre-Exposure Prophylaxis (PrEP) has demonstrated efficacy in the reduction of sexually transmitted HIV infections. The prolonged use of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) co-formulation (TDF/FTC), however, may result in augmented risk of renal toxicity. We aimed to evaluate changes in the estimated Glomerular Filtration Rat...

Alternative Titles

Full title

Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dd67a1f19aa74d5c92e2729047f7397f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd67a1f19aa74d5c92e2729047f7397f

Other Identifiers

ISSN

1742-6405

E-ISSN

1742-6405

DOI

10.1186/s12981-022-00437-4

How to access this item